Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
|Aevi Genomic Medicine Enters into Licens...||08/07/19|
|Plan to enter Phase 2 in Adult Onset Still's Disease and other serious rare and orphan diseases PHILADELPHIA , Aug. 7, 2019 /PRNewswire/ -- Aevi Genom...|
|Aevi Genomic Medicine to Present at the ...||08/06/19|
|PHILADELPHIA , Aug. 6, 2019 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX, "the Company") today announced that Michael F. Cola , President...|
|Date||2019-08-22 (BMO)||Est. (EPS/Rev.)||($0.16)/ 0|
|Actual (EPS/Rev.)||/||EPS (TTM)||0|